NCT07001670 Investigation of the Effects of Tele-Yoga Training in Individuals With Lung Cancer Undergoing Lung Resection Surgery
| NCT ID | NCT07001670 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University |
| Condition | Postoperative Period |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-06-10 |
| Primary Completion | 2026-09-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-06-10 with a primary completion date of 2026-09-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled clinical trial aims to evaluate the effects of an 8-week tele-yoga intervention in individuals with lung cancer who have undergone lung resection surgery. The intervention group will receive supervised yoga sessions via online synchronous video conferencing, while the control group will continue with standard post-operative care. The primary outcome is exercise capacity (6-minute walk test), with secondary outcomes including pulmonary function, respiratory and peripheral muscle strength, physical activity level, dyspnea, fatigue, sleep quality, anxiety and depression, and quality of life. It is hypothesized that tele-yoga will improve physical and psychological recovery post-surgery and may serve as a feasible home-based pulmonary rehabilitation alternative.
Eligibility Criteria
Inclusion Criteria: * Aged between 18 and 65 years, * Histologically confirmed diagnosis of Stage I-IIIA lung cancer according to the 9th edition of the AJCC Cancer Staging Manual, * Underwent lobectomy, pneumonectomy, segmentectomy, or wedge resection via video-assisted thoracoscopic surgery (VATS) or robot-assisted thoracoscopic surgery (RATS), * An estimated life expectancy of ≥6 months, * Karnofsky Performance Status score greater than 80% at study entry, * Possession of the necessary equipment and access to a stable internet connection to enable participation in online interventions. Exclusion Criteria: * History of receiving radiotherapy or chemotherapy prior to surgery, * Presence of severe dysfunction in vital organs such as the heart, brain, kidneys, or others, * Having any comorbid condition that contraindicates participation in an exercise training program, * Presence of serious postoperative complications, * Cognitive impairments that hinder effective communication, * Current participation in a structured and regular exercise program, * Missing three consecutive weeks of sessions or completing less than 75% of the prescribed exercises, * Voluntary withdrawal from the study by the participant.
Contact & Investigator
Rengin Demir, Prof
PRINCIPAL INVESTIGATOR
Istanbul University - Cerrahpasa
Frequently Asked Questions
Who can join the NCT07001670 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Postoperative Period. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07001670 currently recruiting?
Yes, NCT07001670 is actively recruiting participants. Contact the research team at sevdebetulyigit@gmail.com for enrollment information.
Where is the NCT07001670 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07001670 clinical trial?
NCT07001670 is sponsored by Istanbul University. The principal investigator is Rengin Demir, Prof at Istanbul University - Cerrahpasa. The trial plans to enroll 40 participants.